Johnson & Johnson Sued Over Retina Damaging Drug

Johnson & Johnson Sued Over Retina Damaging Drug
Jun 15, 2021 Gayle Gerling Pettinga Read Time: < 1 minute

Multiple lawsuits are outstanding against Johnson & Johnson Pharmaceuticals and Janssen Pharmaceuticals after patients taking Elmiron developed permanent retinal injuries.

Elmiron, which is used to treat interstitial cystitis,  is also known as pentosan polysulfate sodium (PPS). Individuals currently taking Elmiron should obtain an eye examination.

The pharmaceutical companies have yet to release a statement on the apparent connection between the drug and maculopathy. 

Source: The National Law Review

By: Gayle Gerling Pettinga

Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.

Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.

(888) 437-5464
Jump to a Topic  Schedule Your Free Consultation